Abstract: The invention is directed sterile to compositions of glucocorticosteroids useful in the prophylaxis and chronic treatment of asthma and other allergic and inflammatory conditions in adults and pediatric patients.

Abstract: A retractor tool has a hollow shaft with a proximal end and a distal end. The shaft has an internal bore sized to slidable receive an elongated tool of predetermined dimensions with a distal end of said tool exposed through a distal end of the bore. Such tool may be a visualization tool or other tool used in surgery. A first pivoting jaw and a second jaw are both secured to the distal end of the shaft to pivot about first and second pivot axes perpendicular to an axis of the shaft. The jaws pivot between open and closed positions. In the closed positions, opposing surfaces of the jaws define a distal end of the bore extending completely between the jaws.

Abstract: A band with end sections and an integral pocket assembly can be used as a concealed carry apparatus. The end sections fasten the band around the body or a body extremity. An elastic strap keeps the band snug. Slip resistant material placed in opposition of the pocket assembly keeps the band from slipping.

Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.

Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.

Abstract: The present invention is directed to nanoparticulate compositions comprising metaxalone. The metaxalone particles of the composition have an effective average particle size of less than about 2 microns.

Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.

Abstract: The present invention is directed to nanoparticulate compositions comprising meloxicam. The meloxicam particles of the composition have an effective average particle size of less than about 2000 nm.

Abstract: Nanoparticulate compositions comprising at least one poorly soluble angiogenesis inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods of making and using such compositions.

Abstract: The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm.

Abstract: A carbon dioxide fill manifold and method for using which is designed to provide a end-user with an uninterrupted supply of carbon dioxide gas, while at the same time eliminating the necessity of transporting individual, conventional pressurized bottles to be refilled. In a most preferred embodiment the carbon dioxide fill manifold includes a fill line valve connected to an atomizer for receiving a fill line and introducing liquid carbon dioxide into the atomizer, liquid cylinder ports provided in the atomizer for connecting a pair of liquid chambers to the atomizer and receiving and storing the liquid carbon dioxide, a gas cylinder port provided in the atomizer for connecting a vapor container to the atomizer and receiving gaseous carbon dioxide generated in the atomizer and a service line valve also connected to the atomizer for receiving a service lien valve and servicing the end user with gaseous carbon dioxide.

Abstract: A carbon dioxide fill manifold which is designed to provide an end-user with an uninterrupted supply of carbon dioxide gas, while at the same time eliminating the necessity of transporting individual, conventional pressurized bottles to be refilled. The carbon dioxide fill manifold includes a fill line having a fill line valve therein for introducing liquid carbon dioxide into the system, one or more liquid chambers communicating with the fill line for receiving and storing liquid carbon dioxide, a liquid transfer line extending from the fill line to an atomizer, a service line connected to the atomizer and fitted with at least one vapor container for receiving gaseous carbon dioxide generated in the atomizer and a service line valve provided in the service line for servicing the end user with gaseous carbon dioxide.